Drug Approval Law Will Likely Deter Pharma Delay Tactics
Pharmaceutical manufacturers have used many strategies to delay competition from lower-cost equivalent products over the years. While so-called pay-for-delay has garnered more media attention, manufacturers have also blocked competition by denying...To view the full article, register now.
Already a subscriber? Click here to view full article